152 related articles for article (PubMed ID: 18075743)
1. Immunocytology in the assessment of patients with asymptomatic hematuria.
Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Dörsam J; Mellan Z; Bismarck E; Ebert T
World J Urol; 2008 Feb; 26(1):31-7. PubMed ID: 18075743
[TBL] [Abstract][Full Text] [Related]
2. [Role of immunocytology in the evaluation of patients with painless gross hematuria].
Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Dörsam J; Ebert T; Bismarck E
Urologe A; 2010 Jun; 49(6):741-6. PubMed ID: 20373094
[TBL] [Abstract][Full Text] [Related]
3. [Analyses of the role of immunocytology in the differential diagnosis of patients with asymptomatic microhematuria].
Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Beiche B; Bismarck E; Ebert T
Urologe A; 2008 Feb; 47(2):190-4. PubMed ID: 18064433
[TBL] [Abstract][Full Text] [Related]
4. Immunocytology in the assessment of patients with painless gross haematuria.
Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
[TBL] [Abstract][Full Text] [Related]
5. Immunocytology in the assessment of patients with asymptomatic microhaematuria.
Schmitz-Dräger BJ; Beiche B; Tirsar LA; Schmitz-Dräger C; Bismarck E; Ebert T
Eur Urol; 2007 Jun; 51(6):1582-8; discussion 1588. PubMed ID: 17107748
[TBL] [Abstract][Full Text] [Related]
6. Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.
Cha EK; Tirsar LA; Schwentner C; Christos PJ; Mian C; Hennenlotter J; Martini T; Stenzl A; Pycha A; Shariat SF; Schmitz-Dräger BJ
Eur Urol; 2012 Jan; 61(1):185-92. PubMed ID: 21924544
[TBL] [Abstract][Full Text] [Related]
7. Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients.
Feifer AH; Steinberg J; Tanguay S; Aprikian AG; Brimo F; Kassouf W
Urology; 2010 Jun; 75(6):1278-82. PubMed ID: 20138655
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic tests in urology: urine cytology.
Lavallée LT; Fergusson D; Dahm P; Scales CD; Witiuk K; Breau RH
BJU Int; 2012 Dec; 110(11 Pt C):E789-91. PubMed ID: 23106855
[TBL] [Abstract][Full Text] [Related]
9. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
10. Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma.
Todenhöfer T; Hennenlotter J; Tews V; Gakis G; Aufderklamm S; Kuehs U; Stenzl A; Schwentner C
Urol Oncol; 2013 Oct; 31(7):1148-54. PubMed ID: 22130125
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup.
Pak JS; Wang EY; Lee K; Pina LA; McKiernan JM; Anderson CB
Urol Oncol; 2021 May; 39(5):300.e1-300.e6. PubMed ID: 33339726
[TBL] [Abstract][Full Text] [Related]
13. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
[TBL] [Abstract][Full Text] [Related]
14. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
[TBL] [Abstract][Full Text] [Related]
15. Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors.
Pode D; Golijanin D; Sherman Y; Lebensart P; Shapiro A
J Urol; 1998 Feb; 159(2):389-92; discussion 393. PubMed ID: 9649245
[TBL] [Abstract][Full Text] [Related]
16. A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria.
Karnes RJ; Fernandez CA; Shuber AP
Mayo Clin Proc; 2012 Sep; 87(9):835-42. PubMed ID: 22883743
[TBL] [Abstract][Full Text] [Related]
17. Microscopic hematuria as a screening marker for urinary tract malignancies.
Sugimura K; Ikemoto SI; Kawashima H; Nishisaka N; Kishimoto T
Int J Urol; 2001 Jan; 8(1):1-5. PubMed ID: 11168689
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry.
Planz B; Synek C; Deix T; Böcking A; Marberger M
Anal Cell Pathol; 2001; 22(3):103-9. PubMed ID: 11455029
[TBL] [Abstract][Full Text] [Related]
19. Commentary: the role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria.
Trivedi D; Messing EM
BMC Urol; 2009 Sep; 9():13. PubMed ID: 19744318
[TBL] [Abstract][Full Text] [Related]
20. Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria.
Miyanaga N; Akaza H; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
Int J Urol; 1999 Apr; 6(4):173-7. PubMed ID: 10226833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
